{"transactions":[{"id":948581,"issuer":{"id":7919,"kind":"organization","name":"Theriva Biologics, Inc."},"owners":[{"id":70144,"kind":"person","name":"Kraws Jeffrey J","position":1,"cik":"0001380918","reported_name":"Kraws Jeffrey J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2026-01-06T21:53:11.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These stock options vest pro rata on a monthly basis over 12 months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options vest pro rata on a monthly basis over 12 months."}],"balance_after":75000,"derivative":{"exercise_price":0.241,"exercise_date":"2026-02-01","expiration_date":"2033-01-04","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001104659-26-001383","document":"tm262266-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/894158/000110465926001383/tm262266-2_4seq1.xml","form_type":"4"}},{"id":1162853,"issuer":{"id":7919,"kind":"organization","name":"Theriva Biologics, Inc."},"owners":[{"id":70144,"kind":"person","name":"Kraws Jeffrey J","position":1,"cik":"0001380918","reported_name":"Kraws Jeffrey J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2025-05-01T20:01:06.000Z","date":"2025-04-29","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These stock options vest pro rata on a monthly basis over 12 months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options vest pro rata on a monthly basis over 12 months."}],"balance_after":25000,"derivative":{"exercise_price":1.4144,"exercise_date":"2025-05-01","expiration_date":"2032-04-29","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-25-043507","document":"tm2513725-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/894158/000110465925043507/tm2513725-1_4seq1.xml","form_type":"4"}},{"id":1710171,"issuer":{"id":7919,"kind":"organization","name":"Theriva Biologics, Inc."},"owners":[{"id":70144,"kind":"person","name":"Kraws Jeffrey J","position":1,"cik":"0001380918","reported_name":"Kraws Jeffrey J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2023-12-15T21:00:21.000Z","date":"2023-12-14","kind":"grant","planned":false,"acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These stock options vest pro rata on a monthly basis over 12 months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options vest pro rata on a monthly basis over 12 months."}],"balance_after":110000,"derivative":{"exercise_price":0.5875,"exercise_date":"2024-01-14","expiration_date":"2030-12-14","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001104659-23-126371","document":"tm2332964-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/894158/000110465923126371/tm2332964-3_4seq1.xml","form_type":"4"}},{"id":2084397,"issuer":{"id":7919,"kind":"organization","name":"Theriva Biologics, Inc."},"owners":[{"id":70144,"kind":"person","name":"Kraws Jeffrey J","position":1,"cik":"0001380918","reported_name":"Kraws Jeffrey J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2022-12-16T23:17:41.000Z","date":"2022-12-15","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These stock options vest pro rata on a monthly basis over 12 months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options vest pro rata on a monthly basis over 12 months."}],"balance_after":100000,"derivative":{"exercise_price":0.58,"exercise_date":"2023-01-15","expiration_date":"2029-12-15","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-22-127975","document":"tm2232925-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/894158/000110465922127975/tm2232925-5_4seq1.xml","form_type":"4"}},{"id":2458934,"issuer":{"id":7919,"kind":"organization","name":"Theriva Biologics, Inc."},"owners":[{"id":70144,"kind":"person","name":"Kraws Jeffrey J","position":1,"cik":"0001380918","reported_name":"Kraws Jeffrey J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2021-12-27T22:03:34.000Z","date":"2021-12-23","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These stock options vest pro rata on a monthly basis over 12 months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options vest pro rata on a monthly basis over 12 months."}],"balance_after":200000,"derivative":{"exercise_price":0.3314,"exercise_date":"2022-01-23","expiration_date":"2028-12-23","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001104659-21-153627","document":"tm2136313-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/894158/000110465921153627/tm2136313-1_4seq1.xml","form_type":"4"}},{"id":2928082,"issuer":{"id":7919,"kind":"organization","name":"Theriva Biologics, Inc."},"owners":[{"id":70144,"kind":"person","name":"Kraws Jeffrey J","position":1,"cik":"0001380918","reported_name":"Kraws Jeffrey J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-12-31T21:30:24.000Z","date":"2020-12-30","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These stock options will vest pro rata on a monthly basis over 12 months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options will vest pro rata on a monthly basis over 12 months."}],"balance_after":150000,"derivative":{"exercise_price":0.417,"exercise_date":"2021-01-30","expiration_date":"2027-12-30","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001104659-20-140991","document":"tm2039654d1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/894158/000110465920140991/tm2039654d1_4seq1.xml","form_type":"4"}},{"id":2967653,"issuer":{"id":8648,"kind":"organization","name":"Flyte Aviation, Inc."},"owners":[{"id":70144,"kind":"person","name":"Kraws Jeffrey J","position":1,"cik":"0001380918","reported_name":"Kraws Jeffrey J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-President"}}],"security":"Common Stock","published_at":"2020-11-24T16:37:53.000Z","date":"2020-11-20","kind":"grant","acquired":true,"shares":200,"price":5.4315,"value":1086.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired through the issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On November 16, 2020, the common stock of the company reverse-split 25-for-1, resulting in the reporting persons ownership being reduced by 128,006."}],"balance_after":5533,"source":{"system":"sec-edgar","filing":"0001209191-20-060220","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1380918/000120919120060220/doc4.xml","form_type":"4"}},{"id":3066983,"issuer":{"id":8648,"kind":"organization","name":"Flyte Aviation, Inc."},"owners":[{"id":70144,"kind":"person","name":"Kraws Jeffrey J","position":1,"cik":"0001380918","reported_name":"Kraws Jeffrey J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-President"}}],"security":"Warrants (right to buy)","published_at":"2020-08-05T17:14:36.000Z","date":"2020-08-03","kind":"purchase","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10000,"derivative":{"exercise_price":0.35,"exercise_date":"2020-08-03","expiration_date":"2025-08-04","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-045195","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1380918/000120919120045195/doc4.xml","form_type":"4"}},{"id":3066982,"issuer":{"id":8648,"kind":"organization","name":"Flyte Aviation, Inc."},"owners":[{"id":70144,"kind":"person","name":"Kraws Jeffrey J","position":1,"cik":"0001380918","reported_name":"Kraws Jeffrey J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-President"}}],"security":"Common Stock","published_at":"2020-08-05T17:14:36.000Z","date":"2020-08-03","kind":"purchase","acquired":true,"shares":10000,"price":0.35,"value":3500.0,"ownership":{"direct":true},"balance_after":133339,"source":{"system":"sec-edgar","filing":"0001209191-20-045195","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1380918/000120919120045195/doc4.xml","form_type":"4"}},{"id":3133283,"issuer":{"id":8648,"kind":"organization","name":"Flyte Aviation, Inc."},"owners":[{"id":70144,"kind":"person","name":"Kraws Jeffrey J","position":1,"cik":"0001380918","reported_name":"Kraws Jeffrey J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-President"}}],"security":"Common Stock","published_at":"2020-05-27T17:08:37.000Z","date":"2020-05-22","kind":"purchase","acquired":true,"shares":10000,"price":0.46,"value":4600.0,"ownership":{"direct":true},"balance_after":123339,"source":{"system":"sec-edgar","filing":"0001209191-20-032338","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1380918/000120919120032338/doc4.xml","form_type":"4"}},{"id":3330941,"issuer":{"id":8648,"kind":"organization","name":"Flyte Aviation, Inc."},"owners":[{"id":70144,"kind":"person","name":"Kraws Jeffrey J","position":1,"cik":"0001380918","reported_name":"Kraws Jeffrey J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-President"}}],"security":"Common Stock","published_at":"2019-12-26T16:06:47.000Z","date":"2019-12-20","kind":"tax_withholding","acquired":false,"shares":792,"price":0.901,"value":713.592,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.  This is not an open market sale of securities."}],"balance_after":113339,"source":{"system":"sec-edgar","filing":"0001209191-19-061922","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1380918/000120919119061922/doc4.xml","form_type":"4"}},{"id":3350252,"issuer":{"id":7919,"kind":"organization","name":"Theriva Biologics, Inc."},"owners":[{"id":70144,"kind":"person","name":"Kraws Jeffrey J","position":1,"cik":"0001380918","reported_name":"Kraws Jeffrey J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-12-06T12:13:16.000Z","date":"2019-12-04","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These stock options vest as follows: 1/3 will vest on the one year anniversary of the grant date, 1/3 will vest on the two year anniversary of the grant date and the remaining 1/3 will vest on the three year anniversary of the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options vest as follows: 1/3 will vest on the one year anniversary of the grant date, 1/3 will vest on the two year anniversary of the grant date and the remaining 1/3 will vest on the three year anniversary of the grant date."}],"balance_after":250000,"derivative":{"exercise_price":0.418,"exercise_date":"2019-12-04","expiration_date":"2026-12-04","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001104659-19-070375","document":"tm1923941d3_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/894158/000110465919070375/tm1923941d3_form4.xml","form_type":"4"}},{"id":3350637,"issuer":{"id":8648,"kind":"organization","name":"Flyte Aviation, Inc."},"owners":[{"id":70144,"kind":"person","name":"Kraws Jeffrey J","position":1,"cik":"0001380918","reported_name":"Kraws Jeffrey J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-President"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-05T18:23:13.000Z","date":"2019-12-03","kind":"grant","acquired":true,"shares":139052,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/36 of the total shares subject to the option shall vest every month after December 3, 2019, such that all shares shall be fully vested on December 3, 2022, subject to the Reporting Person continuing to be a \"Service Provider\" (as defined in the Company's 2018 Equity Incentive Plan) through each vesting date."}],"balance_after":139052,"derivative":{"exercise_price":1.22,"expiration_date":"2029-12-03","underlying":"Common Stock","underlying_shares":139052},"source":{"system":"sec-edgar","filing":"0001209191-19-059371","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1380918/000120919119059371/doc4.xml","form_type":"4"}},{"id":3350636,"issuer":{"id":8648,"kind":"organization","name":"Flyte Aviation, Inc."},"owners":[{"id":70144,"kind":"person","name":"Kraws Jeffrey J","position":1,"cik":"0001380918","reported_name":"Kraws Jeffrey J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-President"}}],"security":"Common Stock","published_at":"2019-12-05T18:23:13.000Z","date":"2019-12-04","kind":"tax_withholding","acquired":false,"shares":38372,"price":1.8219,"value":69909.9468,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.  This is not an open market sale of securities."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted share price of an aggregate total of 38,372 shares withheld in the price range of $1.69 to $1.96 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares withheld at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Of the reported shares 2,315 shares are represented by Restricted Stock Units."}],"balance_after":114131,"source":{"system":"sec-edgar","filing":"0001209191-19-059371","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1380918/000120919119059371/doc4.xml","form_type":"4"}},{"id":3457301,"issuer":{"id":8648,"kind":"organization","name":"Flyte Aviation, Inc."},"owners":[{"id":70144,"kind":"person","name":"Kraws Jeffrey J","position":1,"cik":"0001380918","reported_name":"Kraws Jeffrey J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-President"}}],"security":"Common Stock","published_at":"2019-07-23T11:50:01.000Z","date":"2019-07-18","kind":"sale","acquired":false,"shares":11930,"price":2.9314,"value":34971.602,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Reporting Person's award agreement to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Of the reported shares  92,384 shares are represented by Restricted Stock Units."}],"balance_after":152503,"source":{"system":"sec-edgar","filing":"0001209191-19-042949","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1380918/000120919119042949/doc4.xml","form_type":"4"}},{"id":3487400,"issuer":{"id":8648,"kind":"organization","name":"Flyte Aviation, Inc."},"owners":[{"id":70144,"kind":"person","name":"Kraws Jeffrey J","position":1,"cik":"0001380918","reported_name":"Kraws Jeffrey J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-President"}}],"security":"Common Stock","published_at":"2019-06-17T17:25:11.000Z","date":"2019-06-13","kind":"sale","acquired":false,"shares":18021,"price":3.0763,"value":55438.0023,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Reporting Person's award agreement to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Of the reported shares 136,297 shares are represented by Restricted Stock Units."}],"balance_after":164433,"source":{"system":"sec-edgar","filing":"0001209191-19-037452","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1380918/000120919119037452/doc4.xml","form_type":"4"}},{"id":3740315,"issuer":{"id":7919,"kind":"organization","name":"Theriva Biologics, Inc."},"owners":[{"id":70144,"kind":"person","name":"Kraws Jeffrey J","position":1,"cik":"0001380918","reported_name":"Kraws Jeffrey J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2018-12-07T22:02:31.000Z","date":"2018-12-06","kind":"grant","acquired":true,"shares":79500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options will vest monthly on a pro rata basis over 36 consecutive months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options will vest monthly on a pro rata basis over 36 consecutive months."}],"balance_after":79500,"derivative":{"exercise_price":0.6895,"exercise_date":"2018-12-06","expiration_date":"2025-12-06","underlying":"Common Stock","underlying_shares":79500},"source":{"system":"sec-edgar","filing":"0001144204-18-063630","document":"tv508648_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/894158/000114420418063630/tv508648_4.xml","form_type":"4"}},{"id":4124328,"issuer":{"id":7919,"kind":"organization","name":"Theriva Biologics, Inc."},"owners":[{"id":70144,"kind":"person","name":"Kraws Jeffrey J","position":1,"cik":"0001380918","reported_name":"Kraws Jeffrey J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2017-12-21T22:20:34.000Z","date":"2017-12-20","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These stock options vest in full on the one year anniversary of the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options vest in full on the one year anniversary of the grant date."}],"balance_after":200000,"derivative":{"exercise_price":0.52,"exercise_date":"2018-12-20","expiration_date":"2024-12-19","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001144204-17-064828","document":"tv481802_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/894158/000114420417064828/tv481802_4.xml","form_type":"4"}},{"id":4383107,"issuer":{"id":7919,"kind":"organization","name":"Theriva Biologics, Inc."},"owners":[{"id":70144,"kind":"person","name":"Kraws Jeffrey J","position":1,"cik":"0001380918","reported_name":"Kraws Jeffrey J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2017-03-16T22:52:37.000Z","date":"2017-03-14","kind":"exercise","acquired":false,"shares":228773,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a 1-for-3 reverse stock split effected in 2007."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a 1-for-3 reverse stock split effected in 2007."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects a 1-for-3 reverse stock split effected in 2007."}],"balance_after":0,"derivative":{"exercise_price":0.09,"exercise_date":"2006-01-01","expiration_date":"2017-03-20","underlying":"Common Stock","underlying_shares":228773},"source":{"system":"sec-edgar","filing":"0001144204-17-015198","document":"v462045_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/894158/000114420417015198/v462045_4.xml","form_type":"4"}},{"id":4383106,"issuer":{"id":7919,"kind":"organization","name":"Theriva Biologics, Inc."},"owners":[{"id":70144,"kind":"person","name":"Kraws Jeffrey J","position":1,"cik":"0001380918","reported_name":"Kraws Jeffrey J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-16T22:52:37.000Z","date":"2017-03-14","kind":"exercise","acquired":true,"shares":228773,"price":0.09,"value":20589.57,"ownership":{"direct":true},"balance_after":228773,"source":{"system":"sec-edgar","filing":"0001144204-17-015198","document":"v462045_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/894158/000114420417015198/v462045_4.xml","form_type":"4"}},{"id":4536019,"issuer":{"id":7919,"kind":"organization","name":"Theriva Biologics, Inc."},"owners":[{"id":70144,"kind":"person","name":"Kraws Jeffrey J","position":1,"cik":"0001380918","reported_name":"Kraws Jeffrey J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2016-12-02T22:03:44.000Z","date":"2016-11-30","kind":"grant","acquired":true,"shares":168750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These stock options vest as follows: 1/3 vested on the grant date, 1/3 will vest on the one year anniversary of the grant date and the remaining 1/3 will vest on the two year anniversary of the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options vest as follows: 1/3 vested on the grant date, 1/3 will vest on the one year anniversary of the grant date and the remaining 1/3 will vest on the two year anniversary of the grant date."}],"balance_after":168750,"derivative":{"exercise_price":0.8,"exercise_date":"2016-11-30","expiration_date":"2023-11-29","underlying":"Common Stock","underlying_shares":168750},"source":{"system":"sec-edgar","filing":"0001144204-16-137739","document":"v454260_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/894158/000114420416137739/v454260_4.xml","form_type":"4"}}]}